How Is The Market Feeling About Pacific Biosciences?
Portfolio Pulse from Benzinga Insights
Pacific Biosciences (NYSE:PACB) has seen an 18.14% increase in short percent of float since its last report, with 40.38 million shares sold short, representing 16.74% of available shares. This indicates a bearish market sentiment towards PACB, although it has more short interest than its peers, with an average of 4.74% in its peer group.
March 12, 2024 | 7:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Pacific Biosciences has experienced a significant increase in short interest, indicating a bearish sentiment among investors.
The increase in short interest for PACB suggests that investors are becoming more bearish on the stock. This could lead to increased selling pressure in the short term, potentially causing the stock price to decrease. The comparison with its peers, where PACB has a significantly higher short interest, further emphasizes the negative sentiment towards the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100